Akin Akinc
@akinakinc
CEO of @AeraTx. Alum of @Alnylam. Views expressed are my own.
ID: 911780209086562305
24-09-2017 02:31:56
34 Tweet
189 Takipçi
71 Takip Edilen
Josh Wolfe
@wolfejosh
Co-Founder @Lux_Capital | Trustee @SfiScience Santa Fe Inst | Founding Chair @CiPrep (Brooklyn) | Co-Founder of Carson, Quinn & Bodhi w/ @ltwolfe
David R. Liu
@davidrliu
Professor at Harvard, Broad Institute, & HHMI. Our lab integrates chemistry & evolution to illuminate biology & enable new therapeutics. IG/Threads: @davidrliu1
Oncology Times
@oncologytimes
Reporting essential clinical news w/ independent analysis for cancer care professionals to optimize patient care & outcomes; oncology/hematology
Dan Budwick
@danbudwick
Founder/CEO, @1ABMedia. Brand builder & C-suite advisor for biotechs and VCs. Secretary/Director, LJ Piniella Foundation. Jersey guy/NY sports fan living in FL
ASCO
@asco
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.
NEJM
@nejm
The New England Journal of Medicine is the world’s leading medical journal and website.
GV
@gvteam
Launched as Google Ventures in 2009, GV supports innovative founders moving the world forward.
Ivan Zlatev
@killinfectdhost
σcience, βiotech, μzik, φotography... Researcher @Alnylam. Opinions are my own.
BioWorld
@bioworld
Biopharma’s trusted news source. Lynn Yoffee, Jennifer Boggs, Karen Carey, Anette Breindl, Lee Landenberger, Randy Osborne, Mari Serebrov, Caroline Richards
Meg Tirrell
@megtirrell
Medical correspondent @CNN
Luke Timmerman
@ldtimmerman
Biotech journalist. Founder @TimmermanReport.
David Schenkein
@schenkein
General Partner @GVteam Hematologist/Medical Oncologist
The ASCO Post
@ascopost
News and views from the world of clinical oncology and hematology
John Carroll
@johncendpts
47 yrs before the mast. Invented FierceBiotech, founded Endpoints News w/ 230,000 subs. Devoting time to the big showdown with Merkel cell carcinoma . We'll see
Christoph Westphal
@drcwestphal
mdphd/hms vc/@longwoodfund founder/ceo/invest ALNY MNTA XLRN SIRT VSTM TCRX etc; ~20 approved drugs helping patients; building biotech at scale
Wei Zhao
@zhaoweiasu
Interested in 🧬 Gene Editing || Science Enthusiast || Author of An Undisclosed Book || Not Financial Advice
Allison DeAngelis
@adeangelis_bio
Reporter covering biopharma startups and venture capital at @statnews. Formerly @thisisinsider and @bosbizjournal.
Brad Loncar
@bradloncar
#Biotech, Founder of @BiotechTVHQ, KC native, @univmiami hurricane.🧬🙌
John LaMattina
@john_lamattina
Dr. John LaMattina, senior partner PureTech Health, author & former president of Pfizer Global R&D.
NeedhamDrivingSchool
@needhamdriving
Needham Driving School has over 50 years of combined experience in the driver education field.
John Evans
@john_evans3
CEO, Beam Therapeutics. We are working on creating precision genetic medicines using base editing. (tweets are my own)
Jason Mast
@jasonmmast
Writing about science, medicine & business for @statnews Email me: [email protected]
Rosana Kapeller
@kapellerrosana
Co-founder & CEO @Rome_Tx, working to harness the repeatome to transform care for patients. Board member, advisor, mother of three and avid reader.
Dr. Yvonne Greenstreet
@ygreenst
CEO at @Alnylam Pharmaceuticals which is leading the RNAi revolution. Views are my own.
Jason Shepherd
@jasonsynaptic
🇿🇦🇳🇿🇺🇸Professor of Neurobiology @UUtah. Molecular mechanisms of memory, repurposed transposons, and virus-like intercellular signaling. Personal opinions.
Oligonucleotide Therapeutics Society
@otsociety
A nonprofit forum to foster academia and industry based research and development of oligonucleotide therapeutics.
Journal of Clinical Oncology
@jco_asco
@ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, & @JCOPO_ASCO.
Editas Medicine
@editasmed
At Editas Medicine, we are harnessing the potential of CRISPR gene editing to develop medicines for people living with serious diseases
Angelos Georgakis
@angelosgeo
Executive Coach to Biotech Leaders • Author of the Biotech Leader’s Handbook • Tweets on: biotech, CEO excellence, high-performing teams, culture
Caribou Biosciences
@cariboubio
Clinical-stage biopharmaceutical company developing transformative therapies to treat devastating human diseases
Intellia Therapeutics
@intelliatx
We're a #GeneEditing company, developing novel, potentially curative therapeutics leveraging #CRISPR-based technologies. Guidelines: ow.ly/CHPD30iXX1p
CRISPR Therapeutics
@crisprtx
Art Krieg
@artkrieg
moved to Bluesky, @ArtKrieg
Ryan Cross the Science Boss
@rlcscienceboss
Senior Science Correspondent for @Endpts covering biotech, drug discovery, gene editing, RNA, and more. Formerly at Boston Globe and C&EN. Signal: RyanCross.25
Andrew Dunn
@andrewe_dunn
Senior biopharma correspondent at @endpts | Previously @BusinessInsider @BioPharmaDive | [email protected]
Feng Zhang
@zhangf
Engineer and molecular biologist. Curious about the world and optimistic to make it better.
CRISPR News 🧬
@crispr_news
The latest CRISPR breakthroughs @crispr-news.bsky.social
Endpoints News
@endpts
The biopharma world is here. Get the industry’s most comprehensive daily news reports at endpts.com/subscribe
Verve Therapeutics
@vervetx
Rachel King 🧬
@iambio_ceo
CEO of @IAmBiotech
Punit Seth
@oligochemist
Creating new oligo modifications and delivery strategies to enable RNA therapeutics - Views expressed are my own
Capstan Therapeutics
@capstantx
Multiplying the therapeutic possibilities for patients by developing targeted in vivo RNA technologies.
Aera Therapeutics
@aeratx
Founded with a vision to unlock the potential of genetic medicines
BiotechTV
@biotechtvhq
News, stories, and educational videos about the biotechnology sector. Bringing biotech to life. 📺
Ionis
@ionispharma
Delivering innovative medicines to patients where no others have proven effective or existed. See our community guidelines: bit.ly/2wds61q
Third Rock Ventures
@thirdrockv
FDA Oncology
@fdaoncology
FDA Oncology Center of Excellence expedites medical product development to improve the lives of people with cancer.
The CRISPR Journal
@crisprjournal
Cutting-edge peer-reviewed research and analysis on genome editing for the global CRISPR community. EIC @crisprchef; Exc Ed @kevinadavies; Publisher @liebertpub
Vasant Jadhav
@vasantrjadhav
CTO at Alnylam. Via RPI, Sirna, Merck to Alnylam. Opinions/likes/RT mine & not endorsements
Beam Therapeutics
@beamtx
Our vision is to provide life-long cures for patients suffering from serious diseases. #DaretoBeam #BeamTeam